Impacting global healthcare with rapid, easy to use, point-of-care tests.

RPS Diagnostics is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases. RPS products are developed using a unique and innovative patented technology platform which the company can utilize to develop a variety of cost-effective tests.

RPS tests allow healthcare providers to more accurately diagnose diseases, provide appropriate and timely treatment, and reduce healthcare costs associated with spread of disease and unnecessary treatment methods.

Right Diagnosis. Right Treatment. Right Now.


[1] Gonzales R, Malone DC, Maselli JH, Sande MA. Clin Infect Dis 2001;33:757-62. [2] Ambulatory Care Visits to Physician Offices, Hospital Outpatient Departments, and Emergency Departments: United States, 2001–02. Vital and Health Statistics. 2006; series 13, number 159. [3] Rattinger GB, Mullins CD, Zuckerman IH, et al. A sustainable strategy to prevent misuse of antibiotics for acute respiratory infections. PLoS One 2012;7(12):e51147. [4] Ewig, S., and A. Torres. Curr. Opin. Crit. Care. 2002; 8:453-460.